Mild or Intermediate Symptomatic Carotid Lesions: What we need to know about plaque

Ischemic stroke is the main reason behind disability in the world, and it is often followed by death. 

Carotídeas asintomáticas ¿Tenemos todas las respuestas?

The rupture of carotid atherosclerotic plaque and its embolization are the main cause of this entity. 

Different randomized studies have shown that carotid endarterectomy is beneficial in symptomatic patients with 70 to 99% carotid obstruction, but we still need to find evidence to establish the best treatment for mild and intermediate lesions. 

The PARISK study, an observational multicenter prospective trial, included 238 patients with a history of transient ischemic attack (TIA)  or monocular stroke, TIA or minor carotid stroke with mild to moderate ipsilateral carotid lesion. 

Patients were looked at using magnetic resonance imaging (MRI) and computed tomography angiography (AngioTAC) to look at four carotid plaque properties: presence of intraplaque hemorrhage (MRI), (ulceration (AngioTAC), proportion of calcifications (AngioTAC), and total plaque volume (MRI). 

Read also: Symptomatic Carotid Arteries: Early or Late Emergency Revascularization?

Mean age was 69, 71% were men, 86% were hypertensive, 26% diabetic, 49% had a history of myocardial ischemia.

45% presented TIA, 44% stroke and 111% stroke or monocular TIA.

Carotid obstruction (ECST risk score) was 0 to 30% in 73% of patients, 30 to 49% in 23%, and 50 to 69% in the remaining 4%.  

There was 39% intraplaque hemorrhage, 27% ulceration, 7.3% calcification and 1281.5 µL total plaque volume. 

Read also: Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

At 5 year-followup TIA or stroke was associated to presence and total volume of intraplaque hemorrhage (HR: 2.12 [95% CI: 1.02-4.44] for IPH; HR: 1.07 [95% CI: 1.00-1.15] for total plaque volume per 100 µL increase).

Ulcerations and calcifications were not associated to events. 

Conclusion

Intraplaque hemorrhage and total plaque volume are independent risk factor of TIA or recurrent ipsilateral stroke in patients with mild to moderate carotid stenosis. Plaque characteristics will improve decision making. Further study is required to validate plaque characteristics and its implementation in clinical scores. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Carotid Plaque Characteristics Predict Recurrent Ischemic Stroke and TIA. The PARISK (Plaque At RISK) Study.

Reference: Dianne H.K. van Dam-Nolen, et a. J Am Coll Cardiol Img 2022;15:1715–1726.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...